Insulin Aspart Injection — FDA Drug Shortage

No longer listed by FDA — Novo Nordisk, Inc.

The FDA lists a drug shortage record for Insulin Aspart Injection (injection) from Novo Nordisk, Inc. with status No longer listed by FDA. The shortage was first posted on Jul 21, 2025.

Shortage details

Status
No longer listed by FDA
Company
Novo Nordisk, Inc.
Package NDC
73070-102-15
Dosage Form
Injection
Presentation
Insulin Aspart, Injection, 3 mL Insulin Aspart PenFill® cartridge (NDC 73070-102-15)
Initial Posting
Jul 21, 2025

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.